HIF1A‐AS2 predicts poor prognosis and regulates cell migration and invasion in triple‐negative breast cancer
Author:
Affiliation:
1. Department of Thyroid and Breast Surgery Jining No.1 People's Hospital Jining Shandong China
Publisher
Wiley
Subject
Cell Biology,Molecular Biology,Biochemistry
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcb.28337
Reference23 articles.
1. Global cancer statistics, 2012
2. Triple negative breast cancer: the kiss of death
3. Targeting the androgen receptor in triple-negative breast cancer: current perspectives
4. Role of postmastectomy radiotherapy in early-stage (T1–2N0–1M0) triple-negative breast cancer: a systematic review
5. Targeting the Molecular Subtypes of Triple Negative Breast Cancer: Understanding the Diversity to Progress the Field
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Long non-coding RNA HIF1A-AS2 promotes carcinogenesis by enhancing Gli1-mediated HIF1α expression in clear cell renal cell carcinoma;Pathology - Research and Practice;2024-01
2. Roles of lncRNA in the diagnosis and prognosis of triple-negative breast cancer;Journal of Zhejiang University-SCIENCE B;2023-12
3. Prognostic Value of HIF1A-AS3 in Breast cancer;2023-10-17
4. A serum LncRNA signature for predicting prognosis of triple-negative breast cancer;Clinica Chimica Acta;2023-09
5. HOPEXGB: A Consensual Model for Predicting miRNA/lncRNA-Disease Associations Using a Heterogeneous Disease-miRNA-lncRNA Information Network;Journal of Chemical Information and Modeling;2023-08-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3